McKesson Corporation

MCK ·Healthcare, Medical Distribution, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Operating Activities
Net Income $4.76B $3.30B $3.00B $3.56B $1.11B $-4.54B $900.0M $34.0M
Depreciation & Amortization $287.0M $272.0M $279.0M $272.0M $312.0M $344.0M $335.0M $317.0M
Depreciation $256.0M $242.0M $253.0M $248.0M $279.0M $321.0M $321.0M $317.0M
Amortization $276.0M $226.0M $249.0M $236.0M $332.0M $422.0M $462.0M $485.0M
Stock-Based Compensation — — — — — — — —
Net Cash from Operating Activities $6.16B $6.09B $4.31B $5.16B $4.43B $4.54B $4.37B $4.04B
Investing Activities
Capital Expenditures $436.0M $537.0M $431.0M $390.0M $388.0M $451.0M $362.0M $426.0M
Business Acquisitions $3.42B $24.0M $272.0M $867.0M $6.0M $35.0M $133.0M $905.0M
Net Cash from Investing Activities $-3.43B $-733.0M $-1.07B $-542.0M $-89.0M $-415.0M $-579.0M $-1.38B
Financing Activities
Dividends Paid $381.0M $345.0M $314.0M $292.0M $277.0M $276.0M $294.0M $292.0M
Stock Repurchases $4.75B $3.15B $3.03B $3.64B $3.52B $742.0M $1.93B $1.64B
Net Cash from Financing Activities $-4.63B $-3.97B $-3.34B $-4.37B $-6.32B $-1.69B $-2.73B $-2.23B
Net Change in Cash $-1.89B $1.37B $-94.0M $744.0M $-2.46B $2.37B $1.04B $309.0M
Free Cash Flow $5.72B $5.55B $3.88B $4.77B $4.05B $4.09B $4.01B $3.61B
← Newer Page 1 of 3 Older →